Residual colonization by vaccine serotypes in rural South Africa four years following initiation of pneumococcal conjugate vaccine immunization

Background: We evaluated pneumococcal colonization in children and adults between the time of 7-valent pneumococcal conjugate vaccine (PCV) introduction in the immunization program in April 2009 to two years after transitioning to 13-valent PCV in 2011.

Methods: Community-based pneumococcal carriage surveillance was undertaken between May-November 2013 (Period-3; n=1884), with similar surveys in 2009 (Period-1, n=2010) and 2011 (Period-2; n=3659). Households with children below two years had a similar

probability of being sampled in all surveys. Nasopharyngeal swabs were processed using standard methods and serotyped by Quellung.

Results: In children >9-59 months of age, overall pneumococcal colonization prevalence declined from 81.8% in Period-1 to 65.0% in Period-3 (p<0.001). Reductions of 70% (95%CI: 60%-77%; 41.2% vs. 13.6%) in PCV7-serotypes colonization and 66% (95%CI:48%-78%; 15.3% vs. 4.4%) for the six additional PCV-serotypes in PCV13 (PCV13

add6VT) were observed. There was, however, high residual prevalence of colonization by PCV7-serotypes 19F (14.9% vs. 6.3%) and 23F (8.5% vs. 4.1%), despite reduction of 57% (95%CI:35%-80%) and 52% (95%CI:21%-83%), respectively. Among individuals >12 years

of age, there was 61% (95%CI:18%-82%) reduction in PCV7-serotype colonization (3.1% vs. 1.3%; ) and 75% (95%CI: 11%-93%) decrease for PCV13-add6VT (2.1% vs. 0.6%) between Period-1 and Period-3.

Conclusions: The residual prevalence of serotypes 19F and 23F in PCV-immunized and unvaccinated age-groups, four years after introducing PCV in the South African public immunization program, suggests ongoing community transmission and transient vaccine

effects.